Assertion: vasodilator's effect | /r/CapableOf | limit clinical use of vasopressin
Facets:
value: over other splanchnic vasoconstrictors
type: OTHER
Source sentences:
text: Based on older controlled trials and updated American Association for the Study of Liver Diseases guidelines on the management of portal hypertensive bleeding in cirrhosis, the addition of nitroglycerin to vasopressin therapy may effectively control acute variceal bleeding and improve safety; however, significant systemic adverse effects associated with the combination limit the clinical use of vasopressin over other splanchnic vasoconstrictors [AASLD [Garcia-Tsao 2017]],